Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Psychiatria Clinica
|
January 1, 1974
[Lithium poisoning with therapeutic lithium concentrations]
K D Waldmann, J Greger, H Kluge, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
February 17, 1998
The activity of thymidine phosphorylase in the uterine myomas and the myometrium in perimenopausal women
E Miszczak-Zaborska, J Greger, K Wozniak, et al.
Anesthesiology
|
December 19, 2001
Continuous posterior lumbar plexus block for acute postoperative pain control in young children
D Sciard, M Matuszczak, R Gebhard, et al.
Minerva Anestesiologica
|
December 4, 2001
Reduction of operating and recovery room times and overnight hospital stays with interscalene blocks as sole anesthetic technique for rotator cuff surgery
J E Chelly, J Greger, T Al Samsam, et al.
The Journal of Arthroplasty
|
June 13, 2001
Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty
J E Chelly, J Greger, R Gebhard, et al.
Psychiatrische Praxis
|
September 1, 1996
[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence]
A Jakobitsch, H J Haug, J Greger, et al.
Platelets
|
April 12, 2001
Differentiated reactivity of whole blood neonatal platelets to various agonists
T Pietrucha, T Wojciechowski, J Greger, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1996
Effect of substance P and its precursor alpha-protachykinin on intracellular free calcium concentration in human polymorphonuclear leukocytes
D Nowak, E Hrabec, J Greger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2023
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
A Passaro, J Wang, Y Wang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Psychiatria Clinica
|
January 1, 1974
[Lithium poisoning with therapeutic lithium concentrations]
K D Waldmann, J Greger, H Kluge, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
February 17, 1998
The activity of thymidine phosphorylase in the uterine myomas and the myometrium in perimenopausal women
E Miszczak-Zaborska, J Greger, K Wozniak, et al.
Anesthesiology
|
December 19, 2001
Continuous posterior lumbar plexus block for acute postoperative pain control in young children
D Sciard, M Matuszczak, R Gebhard, et al.
Minerva Anestesiologica
|
December 4, 2001
Reduction of operating and recovery room times and overnight hospital stays with interscalene blocks as sole anesthetic technique for rotator cuff surgery
J E Chelly, J Greger, T Al Samsam, et al.
The Journal of Arthroplasty
|
June 13, 2001
Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty
J E Chelly, J Greger, R Gebhard, et al.
Psychiatrische Praxis
|
September 1, 1996
[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence]
A Jakobitsch, H J Haug, J Greger, et al.
Platelets
|
April 12, 2001
Differentiated reactivity of whole blood neonatal platelets to various agonists
T Pietrucha, T Wojciechowski, J Greger, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1996
Effect of substance P and its precursor alpha-protachykinin on intracellular free calcium concentration in human polymorphonuclear leukocytes
D Nowak, E Hrabec, J Greger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2023
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
A Passaro, J Wang, Y Wang, et al.
Page
of 7